Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New program aims to ease burden on heart failure caregivers

NCT ID NCT07220798

Symptom relief Sponsor: Visiting Nurse Service of New York Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 13, 2026 · Updated 2 times

Summary

This study tests a 10-session program called ViCCY for caregivers of heart failure patients who also have mild to moderate memory problems. About 256 caregivers and 60 patients will take part. The goal is to see if the program improves caregivers' mental health and reduces stress.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 316 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2026

Expected to finish

Apr 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 101 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient Inclusion Criteria 1. Older adults (=\>50 years of age) 2. Enrolled in Home Health Care 3. Documented to have HF 4. Mild to moderate CI on the BIMS or OASIS items 5. Able to provide informed consent 6. Able to provide self-report data * Caregiver Inclusion Criteria 1. Adults (=\>18 years of age) 2. Spouse/partner/child or other informal caregiver living with or in close proximity to the patient 3. Caregiver of a home care patient who is currently receiving or recently received services and who has mild to severe cognitive impairment 4. Reporting poor self-care on screening (Health Self-Care Neglect scale score =\>2) 5. Reporting poor mental health on screening (screened with the PROMIS Global Mental Health 4a score \<12) 6. Caregiving or supporting the patient at least 8 hours/week 7. Able to complete the protocol, e.g., adequate vision and hearing, English speaking. 8. Able to provide informed consent 9. Able to use technology Exclusion Criteria: * Patient Exclusion Criteria 1. Dementia (ICD-10 code for dementia) 2. Enrolled in hospice 3. Non-English speaking * Caregiver Exclusion Criteria 1. Non-English speaking

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Caregiver burden are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Caregiver Burden Cognitive Dysfunction heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Caregiver burden Cognitive impairment Heart failure

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • VNS Health

    RECRUITING

    New York, New York, 10017, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.